Someone got over excited last night..about this, apparently...
Stocks of some stem-cell companies gained after news late Tuesday that a U.S.
appeals court said the White House can continue to fund embryonic stem-cell
research while it appeals an August injunction barring such funding. Geron Corp.
(GERN, $5.49, +$0.06, +1.10%), StemCells Inc. (STEM, $0.81, +$0.04, +4.83%) and
Aastrom Biosciences Inc. (ASTM, $1.55, +$0.03, +1.97%) all gained. Most companies
may not be directly affected by the ruling because they don't rely on government
funding, but sector has moved with the story in recent months as stocks will
likely benefit from the field moving forward.
............
The Regenerative summit in Detroit Oct. 4-5 should prove interesting. |
